Amantadine Drug Classification
Amantadine belongs to the adamantane class of antiviral medications. 1, 2, 3
Primary Drug Class
Amantadine is classified as an adamantane, a chemically related class of antiviral drugs that specifically target influenza A viruses by interfering with the M2 ion channel protein 1, 2, 3. The drug is chemically designated as 1-adamantanamine hydrochloride 4.
Mechanism and Spectrum of Activity
- Antiviral mechanism: Adamantanes like amantadine inhibit the M2 ion channel of influenza A virus, blocking viral uncoating and replication 1, 5, 6
- Spectrum: Active against influenza A viruses only; not effective against influenza B 1, 2, 3
- Related drug: Rimantadine is the other adamantane in clinical use, sharing the same mechanism and spectrum 1, 3
Additional Pharmacological Properties
Beyond its antiviral classification, amantadine has dual pharmacological actions 4:
- Anti-Parkinson agent: Used for idiopathic Parkinson's disease, postencephalitic parkinsonism, and drug-induced extrapyramidal reactions 4
- Neurostimulant properties: Increasingly used off-label in neurocritical care for traumatic brain injury and disorders of consciousness 7, 8
Important Clinical Context
Critical limitation: The adamantane class is no longer recommended for influenza treatment or prophylaxis in the United States due to widespread resistance. By 2006, approximately 92% of influenza A (H3N2) viruses demonstrated adamantane resistance 9, 10. Current influenza A strains, including H1N1 and H3N2, show resistance rates of 99% and 10% respectively 9. This has rendered the antiviral indication largely obsolete, though the drug remains valuable for its neurological indications 11.
The neuraminidase inhibitors (oseltamivir and zanamivir) have replaced adamantanes as the primary antiviral agents for influenza 1, 3, 5.